Ptc Therapeutics (PTCT) Leases (2019 - 2025)
Historic Leases for Ptc Therapeutics (PTCT) over the last 7 years, with Q3 2025 value amounting to $80.7 million.
- Ptc Therapeutics' Leases rose 3567.98% to $80.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.7 million, marking a year-over-year increase of 3567.98%. This contributed to the annual value of $56.7 million for FY2024, which is 3831.61% down from last year.
- Latest data reveals that Ptc Therapeutics reported Leases of $80.7 million as of Q3 2025, which was up 3567.98% from $56.2 million recorded in Q2 2025.
- In the past 5 years, Ptc Therapeutics' Leases ranged from a high of $141.6 million in Q2 2022 and a low of $56.2 million during Q2 2025
- Over the past 5 years, Ptc Therapeutics' median Leases value was $80.7 million (recorded in 2021), while the average stood at $83.4 million.
- Its Leases has fluctuated over the past 5 years, first surged by 17377.1% in 2021, then crashed by 4090.66% in 2024.
- Ptc Therapeutics' Leases (Quarter) stood at $77.4 million in 2021, then skyrocketed by 32.3% to $102.4 million in 2022, then fell by 10.28% to $91.9 million in 2023, then plummeted by 38.32% to $56.7 million in 2024, then skyrocketed by 42.33% to $80.7 million in 2025.
- Its Leases stands at $80.7 million for Q3 2025, versus $56.2 million for Q2 2025 and $57.3 million for Q1 2025.